bendamustine hydrochloride has been researched along with cep 8983 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dilley, RL; Gladstone, DE; Herman, JG; Karp, JE; McDevitt, MA; Poh, W; Pratz, KW; Showel, MM | 1 |
1 other study(ies) available for bendamustine hydrochloride and cep 8983
| Article | Year |
|---|---|
Poly(ADP-ribose) polymerase inhibitor CEP-8983 synergizes with bendamustine in chronic lymphocytic leukemia cells in vitro.
Topics: Antineoplastic Agents, Alkylating; B-Lymphocytes; Bendamustine Hydrochloride; BRCA1 Protein; Carbazoles; DNA Damage; DNA Methylation; DNA Repair; DNA Repair Enzymes; DNA, Neoplasm; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation, Leukemic; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Nitrogen Mustard Compounds; Phthalimides; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Promoter Regions, Genetic; Sequence Analysis, DNA; Signal Transduction | 2014 |